XORTX Therapeutics Inc.
XRTX
$2.28
-$0.03-1.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.77M | 1.99M | 1.85M | 1.78M | 1.93M |
| Depreciation & Amortization | 102.60K | 111.90K | 112.10K | 109.10K | 105.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.13M | 2.43M | 2.54M | 2.42M | 2.54M |
| Operating Income | -2.13M | -2.43M | -2.54M | -2.42M | -2.54M |
| Income Before Tax | -3.74M | -2.77M | -2.66M | -1.94M | -1.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.74 | -2.77 | -2.66 | -1.94 | -1.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.74M | -2.77M | -2.66M | -1.94M | -1.88M |
| EBIT | -2.13M | -2.43M | -2.54M | -2.42M | -2.54M |
| EBITDA | -2.11M | -2.38M | -2.47M | -2.35M | -2.46M |
| EPS Basic | -2.75 | -2.65 | -3.00 | -2.36 | -2.71 |
| Normalized Basic EPS | -1.72 | -1.65 | -1.88 | -1.48 | -1.69 |
| EPS Diluted | -2.75 | -2.65 | -3.00 | -2.37 | -2.71 |
| Normalized Diluted EPS | -1.72 | -1.65 | -1.88 | -1.48 | -1.69 |
| Average Basic Shares Outstanding | 5.29M | 4.43M | 3.79M | 3.13M | 2.74M |
| Average Diluted Shares Outstanding | 5.29M | 4.43M | 3.79M | 3.13M | 2.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |